Moreover, there was no significant difference in TMT regarding tumor WHO grade, EGFR expression, ATRX expression, IDH mutation, MGMT promoter methylation, 1p/19q co-deletion, tumor location in the posterior fossa, and maximal tumor diameter (p = n.s. for each). This evidence concerns the gene EGFR and neoplasm.